palliative-stage oncological disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (Hematologic) oncological patients with advanced palliative disease (at least documented progression after first-line therapy) HADS-A and HADS-D = 8 Expected survival of at least 3 months = 18 years of age Available access to the Internet and a PC, laptop, smartphone, or tablet Understanding of the German language, both written and spoken Willingness to participate in an MBSR study / provision of written informed consent
Exclusion criteria
Exclusion criteria: Advanced non-oncological chronic diseases: Child C liver cirrhosis, end-stage renal disease, heart failure NYHA III or IV Previous participation in similar interventions or established active mindfulness practice Cognitive or language barriers that would interfere with the execution of the interventions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HADS-D (Hospital Anxiety and Depression Scale), measured before the start of the intervention (study enrollment), immediately after the intervention (4 weeks after study enrollment), and 4 weeks after completion of the intervention (8 weeks after study enrollment). | — |
Secondary
| Measure | Time frame |
|---|---|
| • EORTC QLQ-C15 PAL • Brief Fatigue Inventory (BFI) • Pittsburgh Sleep Depriviation Scale (PSQI) • Demoralisation Scale • Spiritual Needs Questionaire (SpNQ) • Ehrfurcht-Dankbarkeit-Fragebogen (Awe and Gratitude (GrAw-7)) | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg - Eppendorf